HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
We are proud to share an unequaled level of requirement in our organization, surpassing regulatory standards to deliver excellence.
As a world leader in the healthcare industry, product quality is not just a requirement but an absolute obligation for us.
Our new Quality Policy is rooted in the foundational values of HTL Biotechnology.
It is forward-looking, embodying our leadership’s dedication ๐ญ๐จ ๐๐ง๐ฌ๐ฎ๐ซ๐ข๐ง๐ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐๐ซ ๐ฌ๐๐ญ๐ข๐ฌ๐๐๐๐ญ๐ข๐จ๐ง ๐ญ๐ก๐ซ๐จ๐ฎ๐ ๐ก ๐ข๐ง๐ง๐จ๐ฏ๐๐ญ๐ข๐ฏ๐, ๐ฌ๐๐๐, ๐๐ง๐ ๐๐๐๐๐๐ญ๐ข๐ฏ๐ ๐ฉ๐ซ๐จ๐๐ฎ๐๐ญ๐ฌ.
๐
On October 28, 2025, HTL Biotechnology hosted its first-ever webinar, โShaping the Future of Aesthetic Medicine with Premium Biopolymers,โ a key initiative to strengthen our presence in Asia and promote the โFeel the Difference with HTL Insideโ positioning among major players in aesthetic medicine.
This October, HTL Biotechnology turned pink to support breast cancer prevention.
HTL Biotechnology is the winner of the Responsible Care West Atlantic Trophy in the โEnergy – Climateโ category for its project to reduce carbon emissions from distillation systems.